Código QR (código de barras bidimensional)

Cost-effectiveness Analysis of Reference Infliximab (Remicade) Compared to its Biosimilar (Remsima) in Iraqi Patients with Rheumatoid Arthritis (Conference Paper )#

The study objective was to conduct Pharmacoeconomics study (cost-effective analysis) between infliximab reference (Remicade) and its biosimilar (Remsima) in patients with rheumatoid arthritis (RA) in Iraqi hospitals. This is a retrospective multicenter pharmacoeconomic analysis conducted at two...

ver descrição completa

Na minha lista:
Principais autores: Hasan Raid Fadhil, Ali Azeez Al-Jumaili, Nizar Abdulateef Al-Ani
Formato: Artigo
Idioma:Inglês
Publicado em: College of Pharmacy University of Baghdad 2023-02-01
coleção:Iraqi Journal of Pharmaceutical Sciences
Assuntos:
Cost-effectiveness
Rheumatoid arthritis
Infliximab
Biosimilar
Biological medicine
Quality of life
Acesso em linha:https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2033
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados